Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2022;28(1):91-104. Published online November 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0236

View: 10487 Download: 198 Web of Science: 15 Crossref: 14

Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki

Clin Mol Hepatol. 2015;21(3):249-256. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.249

View: 9295 Download: 86 Web of Science: 13 Crossref: 12

Donghun Lee, Moran Ki, Anna Lee, Kyoung-Ryul Lee, Hee Bong Park, Chang Sub Kim, Bo Young Yoon, Jong Hyun Kim, Young Sok Lee, Sook-Hyang Jeong

Clin Mol Hepatol. 2011;17(1):44-50. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.44

View: 6894 Download: 60 Crossref: 17

1 |

Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 4997	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4672	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4650	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search